We have reported a highly significant reduction in the recurrence rate of neural tube defect in mothers given a periconceptional multivitamin supplement (Pregnavite Forte F) when compared with unsupplemented mothers recorded by the same centres over the same period. ' As our study was not randomised several workers2-5 have suggested that supplemented and unsupplemented mothers had different prior risks of recurrence of neural tube defect and that this, rather than any effect of the vitamins, could be responsible for the observed difference in recurrence rates. In this report supplemented mothers are those referred to as fully supplemented in previous reports-that is, they have taken Pregnavite Forte F from not less than 28 days before conception until the time of the second missed menstrual period.
We report here the distribution in our supplemented and unsupplemented mothers of factors that are known or suspected to modify the risk of occurrence of neural tube defect. Factors affecting the occurrence risk would be expected also to modify the recurrence risk, although there are few direct data to confirm this. We have considered the following factors:
(1) Number of previous neural tube defects. All 'Dicd 5 July 1985. 440 mothers, whether supplemented or unsupplemented, had had at least one previous neural tube defect, but it is known that the rate of recurrence increases in relation to the number of previous neural tube defects. Two or more previous neural tube defects are therefore regarded as indicative of 'high risk'. (2) Social class. A social class gradient has been recognised for many years, the birth prevalence of neural tube defect being lowest in social class I and highest in social class V. One study has reported a similar gradient in recurrence rates. Results Table 1 shows the analysis of individual risk factors. Four factors (>two previous neural tube defects, residence in Ireland, immediately prior spontaneous abortion, and 12 months between abortion and study pregnancy) apparently lead to an increased risk. Only for two or more previous neural tube defects, however, is the increase significant, and when the distribution of the factors between the supplemented and unsupplemented groups is taken into account none of the factors leads to a predicted increase of more than 4% in the recurrence rate in the unsupplemented compared with the supplemented group (Table 1 , right hand column).
In the multivariate analysis in Table 2 the effect of n factors is measured by the reduction in the deviance when they are introduced into the analysis. This reduction has a x2 distribution with n degrees of freedom, and its significance can be found in x2 tables. One factor (-two previous neural tube In our data the recurrence rate after a spontaneous abortion was 5-4% compared with 2-5% after all other outcomes, but this difference was not quite significant (p=006). In our unsupplemented women with one previous neural tube defect the association of neural tube defect with an immediately prior spontaneous abortion is similar to that found by Cuckle.1' The recurrence rate was 8-8% after a spontaneous abortion compared with 3-4% after all other outcomes (p=0-05). The frequency of spontaneous abortion in the immediately prior pregnancy is similar, however, in the supplemented and unsupplemented groups, and the differential risk introduced is only 3%.
5 Immediately prior pregnancy ending in a therapeutic abortion. This happened in 12-4% of supplemented but only 5-2% of unsupplemented women. We have discussed before16 how our method of recruiting mothers for supplementation through genetic counselling clinics leads to an excess of women who have just had a neural tube defect pregnancy. Termination of the immediately prior pregnancy has not been considered before as a possible risk factor, and because of the imbalance between the supplemented and unsupplemented groups it could be important. Table 1 shows, however, that there is no increased risk of neural tube defect when the preceding pregnancy was terminated.
6 Length of fallow period. The excess of spontaneous abortions in the immediately prior pregnancy seems well established. Whether there is a causal connection is less clear. Knox first postulated that residual trophoblast was important in the aetiology of neural tube defect. Clarke suggested that the retention of trophoblast material is much more likely after a spontaneous abortion than after a normal delivery.9 There is little information about the survival of trophoblast in vivo. In vitro human trophoblast material taken from caesarian section at term has been successfully cultured for up to eight months, but a similar technique was not successful with early trophoblast. It seems likely that the longer the interval between the spontaneous abortion and the next conception the less likely is trophoblastic material to remain. Table I shows that there is a threefold increase in the risk of recurrence in pregnancies started within 12 months of an abortion (spontaneous or therapeutic) compared with those with a prior abortion but a fallow period of a year or more. If confirmed, this would be the most powerful risk factor we have found, but the difference does not reach significance (p=0-2). Table 1 shows that this effect does not account for any of the difference in recurrence rate between our supplemented and unsupplemented groups. We have already reported that for all supplemented pregnancies the average time interval between conception and the end of the previous pregnancy was slightly shorter than for unsupplemented pregnancies. ' Most spontaneously aborted fetuses are not examined, and it is therefore possible that some of them have neural tube defects. In the obstetric histories studied by Clarke there is no indication whether aborted fetuses were examined.'4 '" Bell and Gosden examined over 500 unselected spontaneously aborted fetuses and found neural tube defect in 4*1% of them.2" In our study pregnancies roughly half the spontaneously aborted fetuses were examined; neural tube defect was found in 0/19 examined fetuses of supplemented women and 1/25 of unsupplemented women. Although this small sample cannot be assumed to be representative, it suggests that the recurrence rate of neural tube defect among aborted fetuses may be similar to that in full term pregnancies. A small part of the increased recurrence of neural tube defect observed after a spontaneous abortion may therefore be attributable to previous but undetected neural tube defect. The effect of prior spontaneous abortion per se can only be determined by investigating recurrence rates of neural tube defect after spontaneous abortions that were examined and found to be unaffected.
Many questions will remain unanswered until more complete data on a very large number of women are available. It is clear, however, that the difference in recurrence rates of neural tube defect between vitamin supplemented and unsupplemented mothers cannot be attributed to any of the factors considered here, either alone or in combination. Indeed they cannot account for even a twofold difference in prior risk. On the differential risk hypothesis this is surprising: even if none of the factors considered here were the direct cause of the difference, all the likely nutritional, social, and obstetric variables should show some correlation. We cannot totally exclude the possibility that some 'invisible' factor influencing the risk of recurrence has segregated differentially as between supplemented and unsupplemented mothers. If, however, such a factor were causing a sevenfold difference the visible partially correlated factors might be expected to show some difference.
The method used here to look at individual factors may show some small apparent differential risk even if vitamins directly cause the whole of the difference observed. This is because any irrelevant factor that is randomly increased in the unsupplemented group may be scored as a positive risk factor (because most of the recurrences of neural tube defect are in the unsupplemented group), and this positive risk factor will by definition be increased in that group. Hence the small positive contributions by some factors to the risk ratio are not evidence that if a sufficient number of such factors were considered then the whole differential risk could be explained. Further statistical analysis of our vitamin supplementation trial therefore suggests that the highly significant difference in recurrence rates of neural tube defect between supplemented and unsupplemented mothers was not attributable to differential risks between the two groups but to some aspect of vitamin supplementation. It is possible, however, that factors associated with the taking of vitamin tablets-for example, subtle preconceptional changes of life stvle-may have contributed to the reduced recurrence rate of neural tube defect. It remains true that periconceptional vitamin supplementation is associated with a significantly reduced rate.
